2004
DOI: 10.1096/fj.04-2879fje
|View full text |Cite
|
Sign up to set email alerts
|

Submucosal gland dysfunction as a primary defect in cystic fibrosis

Abstract: It has been proposed that defective submucosal gland function in CF airways is a major determinant of CF airway disease. We tested the hypothesis that submucosal gland function is defective early in CF subjects with minimal clinical disease. Functional assays of gland fluid secretion rate and viscosity were performed on freshly obtained nasal biopsies from 6 CF subjects and 5 non-CF controls (age range 2-22 years). Secretions from individual submucosal glands were visualized by light/fluorescence microscopy af… Show more

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
2
1

Citation Types

3
89
0

Year Published

2005
2005
2021
2021

Publication Types

Select...
6
2
1

Relationship

0
9

Authors

Journals

citations
Cited by 76 publications
(92 citation statements)
references
References 25 publications
3
89
0
Order By: Relevance
“…However, the properties of CF gland mucus produced in response to carbachol are altered (5), and their responses appear to be reduced when corrected for the hypertrophied state of CF glands. 3 These results have been independently confirmed (6,7). The direct explanation for these results is that CFTR-mediated fluid secretion is lost in CF glands.…”
mentioning
confidence: 68%
“…However, the properties of CF gland mucus produced in response to carbachol are altered (5), and their responses appear to be reduced when corrected for the hypertrophied state of CF glands. 3 These results have been independently confirmed (6,7). The direct explanation for these results is that CFTR-mediated fluid secretion is lost in CF glands.…”
mentioning
confidence: 68%
“…A wealth of information has been gained by these experiments, leading us to a deeper appreciation of host-pathogen interactions. Although never tested directly, it is estimated that targeting as few as 6% of epithelial cells could correct CF pulmonary disease (45), although evidence suggests that correction of specific structures such as the submucosal glands may also be required (46). Early clinical trials with adenovirus yielded short-term localized expression of CFTR, but a strong immune response to the adenoviral vectors was observed (47)(48)(49).…”
Section: Discussionmentioning
confidence: 99%
“…Thus, secretion by glands to saturating levels of VIP or forskolin (Joo, Irokawa et al 2002), as well as the synergistic increase of gland secretion to combinations of VIP + carbachol, are lost in cystic fibrosis . In contrast, secretion to cholinergic agonists remains robust, although the level of secretion is reduced and the composition is altered Thiagarajah, Song et al 2004;Salinas, Haggie et al 2005;Song, Salinas et al 2006).…”
Section: Airway Submucosal Glandsmentioning
confidence: 99%
“…This method doesn't work well with sheep, pigs or humans, which have mucus that is much thicker than that of the cat (unpublished observations). However, the bubbles of mucus that form under oil in these species can be quantified optically, and single gland secretion rates for these species have been determined for a variety of mediators and conditions, and their pharmacology further studied Joo, Irokawa et al 2002;Joo, Saenz et al 2002;Verkman, Song et al 2003;Thiagarajah, Song et al 2004;Salinas, Haggie et al 2005;Joo, Irokawa et al 2006;Song, Salinas et al 2006). Among the findings of such studies are that vasoactive intestinal peptide (VIP), usually considered to be a muscle relaxant, is a good secretagogue for fluid secretion from pig and human airway glands, as was first suggested based on measures of lactoferrin release (Baraniuk, Lundgren et al 1990).…”
Section: Airway Submucosal Glandsmentioning
confidence: 99%